CD2 |
RM2-5 |
BD Biosciences |
CD3ε |
145-2C11 |
BD Biosciences |
CD5 |
53-7.3 |
BD Biosciences |
CD28 |
37.51 |
BD Biosciences |
CD16/CD32 (FcγRIII/II) |
2.4G2 |
BD Biosciences |
CD124 (IL-4R-α) |
mIL4R-M1 |
BD Biosciences |
Gr-1 (Ly6C and Ly6G) |
RB6-8C5 |
BD Biosciences |
iNOS |
6 |
BD Biosciences |
Ly6G |
1A8 |
BD Biosciences |
Stat6 (pY641) |
J71-773.58.11 |
BD Biosciences |
TNF-α |
MP6-XT22 |
BD Biosciences |
F4/80 |
CI:A3-1 |
Caltag Laboratories (Burlingame, CA, USA) |
IL-4 |
11B11 |
eBioscience (San Diego, CA, USA) |
IL-13 |
eBio13A |
eBioscience |
IL-13Rα2 |
110815 |
R&D Systems (Minneapolis, MN, USA) |
CD68 (macrosialin) |
FA-11 |
AbDSerotec (Raleigh, NC, USA) |
CD206 (mannose receptor) |
MR5D3 |
AbDSerotec |
Dectin-1 (β-glucan receptor) |
2A11 |
AbDSerotec |
Arginase 1 |
polyclonal |
gift of Dr. Sidney Morris, University of Pittsburgh (Pittsburgh, PA, USA) |
Ym1/2 |
polyclonal |
gift of Dr. Shioko Kimura, National Cancer Institute, National Institutes of Health (Rockville, MD, USA) |
Stat6 |
polyclonal |
Santa Cruz Biotechnology (Santa Cruz, CA, USA) |
PStat6 |
polyclonal |
Santa Cruz Biotechnology |